Immucell (ICCC) Current Leases (2020 - 2026)
Immucell's (ICCC) quarterly Current Leases came in at $85489.0 in Q4 2025, down 80.21% YoY from $432072.0 in Q4 2024, and up 3.7% on a QoQ basis from $82442.0 in Q3 2025.
Immucell (ICCC) Current Leases (2020 - 2026) Analysis & Trends
Immucell (ICCC) has 6 years of Current Leases data on file, last reported at $85489.0 in Q4 2025.
- Quarterly Current Leases fell 80.21% year-over-year to $85489.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $85489.0 (down 80.21% YoY) and the FY2025 annual result came in at $85489.0, down 80.21% from the prior year.
- Current Leases advanced to $85489.0 in Q4 2025, from $82442.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $644276.0 in Q4 2023 to a low of $22920.0 in Q3 2022.
- A 5-year average of $220623.1 and a median of $107074.5 in 2021 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases jumped 1928.32% — and 2025, when it plunged 82.9%.
- Tracing ICCC's Current Leases over 5 years: stood at $108012.0 in 2021, then slumped by 70.59% to $31764.0 in 2022, then jumped by 1928.32% to $644276.0 in 2023, then slumped by 32.94% to $432072.0 in 2024, then sank by 80.21% to $85489.0 in 2025.
- The last three Current Leases figures came in at $85489.0 (Q4 2025), $82442.0 (Q3 2025), and $322753.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 121,858.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121,858.00 |
| Dec 31, 2025 | 85,489.00 |
| Sep 30, 2025 | 82,442.00 |
| Jun 30, 2025 | 322,753.00 |
| Mar 31, 2025 | 380,958.00 |
| Dec 31, 2024 | 432,072.00 |
| Sep 30, 2024 | 482,244.00 |
| Jun 30, 2024 | 533,315.00 |
| Mar 31, 2024 | 597,289.00 |
| Dec 31, 2023 | 644,276.00 |
| Sep 30, 2023 | 67,818.00 |
| Jun 30, 2023 | 52,217.00 |
| Mar 31, 2023 | 33,963.00 |
| Dec 31, 2022 | 31,764.00 |
| Sep 30, 2022 | 22,920.00 |
| Jun 30, 2022 | 112,092.00 |
| Mar 31, 2022 | 110,052.00 |
| Dec 31, 2021 | 108,012.00 |
| Sep 30, 2021 | 106,137.00 |
| Jun 30, 2021 | 104,262.00 |